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Schwann cell precursors, derivatives of the neural crest, generate Schwann cells in a process that is tightly timed, well
characterized, and directly controlled by axonal signals, in particular b-neuregulins. Here we provide evidence that
endothelins (ETs) are also important for survival and lineage progression in this system. We show that ETs promote rat
Schwann cell precursor survival in vitro without stimulation of DNA synthesis. Using ET receptor agonists and antagonists,
we demonstrate that this action of ET is mediated by the ETB receptor. RT-PCR reveals the presence of ET and ET receptor
RNA in the developing rat PNS. We showed previously that in vitro b-neuregulins promote the generation of Schwann
ells from precursors on schedule and that this process can be accelerated by fibroblast growth factor 2. Here we show that
lthough ETs promote long-term precursor survival the transition of precursors to Schwann cells is delayed. Moreover, ETs
lock the maturation effects of b-neuregulins. In spotting lethal rats, in which functional ETB receptors are absent, we find
ccelerated expression of the Schwann cell marker S100 in developing nerves. These observations indicate that complex
rowth factor interactions control the timing of Schwann cell development in embryonic nerves and that ETs act as negative
egulators of Schwann cell generation. © 2000 Academic Press
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The Schwann cells of adult nerves are derived from the
trunk neural crest via two defined intermediate stages:
Schwann cell precursors and immature Schwann cells (Mir-
sky and Jessen, 1996; Jessen and Mirsky, 1999). Previously,
we have defined a number of phenotypic changes involved
in the transition from precursors to Schwann cells and
studied the timing of this transition in vivo and in vitro in
the presence of growth factors (Jessen et al., 1994; Dong et
al., 1995; Gavrilovic et al., 1995). Three growth factor
families, primarily neuregulins but also fibroblast growth
factors (FGFs) and insulin-like growth factors (IGFs), have
been implicated as regulators of this early stage of Schwann
cell development. In the present work we identify a fourth
family, the endothelins (ETs), as survival factors for
1 To whom correspondence should be addressed at the Depart-
ment of Anatomy and Developmental Biology, University College
London, Gower Street, London WC1E 6BT, UK. E-mail:
k.jessen@ucl.ac.uk.
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All rights of reproduction in any form reserved.chwann cell precursors and as regulators of the timing of
chwann cell generation in vitro and in vivo.
Schwann cell precursors can be distinguished from the
arly migrating neural crest by the appearance of a survival
esponse to b-neuregulin and the appearance of three differ-
ntiation markers, P0 (the major peripheral myelin protein),
rowth-associated protein 43, and CD9 (Lee et al., 1997;
Jessen et al., 1994; A. Brennan, unpublished observation).
Schwann cell precursors are found in the sciatic nerve at
embryonic day (E) 14–15 in the rat, but by E17, essentially
all cells present in the nerve are immature Schwann cells
(Jessen et al., 1994; Dong et al., 1995). The transition from
precursors to Schwann cells is characterized by changes in
protein and lipid expression. This includes a strong upregu-
lation of the expression of the calcium-binding protein
S100. Schwann cell generation is also accompanied by a
change in the response to mitogens and the appearance of
an autocrine survival circuit involving IGF-2, neuro-
trophin-3, and platelet derived growth factor-BB (Jessen et
al., 1994; Meier et al., 1999). In vitro, Schwann cell precur-
sors die rapidly by apoptosis when they are removed from
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546 Brennan et al.axonal contact unless they are cultured with exogenous
survival factors such as b-neuregulin. In contrast, when
ultured at moderate or high cell density Schwann cells are
ble to survive loss of axonal signals due to production of
utocrine factors.
We have previously shown that b-neuregulins act as
ong-term survival factors for Schwann cell precursors in
itro and that when cultured in the presence of
b-neuregulins, precursors mature into Schwann cells with a
time course essentially the same as that seen for the
generation of Schwann cells from precursors in vivo (Dong
et al., 1995). Studies on transgenic mice support the view
that b-neuregulins also act in vivo as neuron-derived signals
that support precursor survival, migration, and maturation
(Wolpowitz et al., 2000). Despite extensive studies with
ther growth factors, only b-neuregulins and the combina-
tion of FGFs 1, 2, or 4 with IGFs have previously been
identified as survival factors for Schwann cell precursors.
The ETs, which we examine in this paper, belong to a
family of small polypeptide factors related to the sarafotox-
ins. ETs 1, 2, and 3 are encoded by three separate genes and
have strong sequence and structural homology. Each of the
21-amino-acid polypeptides is synthesized as a much larger
precursor molecule, prepro-ET, which is enzymatically
cleaved by a dibasic, pair-specific endopeptidase, possibly
furin (Yanagisawa et al., 1988), to give the relatively inac-
tive pro-ET, also known as big ET. This big ET is then
cleaved by specific neutral metalloproteases known as
endothelin converting enzymes (ECEs) to give mature ac-
tive ET. So far three ECEs have been identified (Xu et al.,
1994; Emoto and Yanagisawa, 1995; Hasegawa et al., 1998).
ET receptors are members of the G-protein-coupled su-
perfamily of receptors. Two subtypes of ET receptor have
been described in mammals, ETA and ETB. ETA receptors
bind ET-1 and ET-2 with high affinity and ET-3 with low
affinity, while ETB receptors are non-isopeptide selective,
binding all three peptides with equal affinity (reviewed in
Pollock, 1998). These receptors have been cloned and are
encoded by separate genes (Arai et al., 1990; Sakurai et al.,
1990).
Endothelins are known to be important for the survival
and proliferation of other neural crest derivatives. Loss of
ET-1 or the ETA receptor leads to craniofacial abnormalities
due to an absence of cranial neural crest (Kurihara et al.,
1994; Clouthier et al., 1998) while mutation in the ET-3 or
the ETB receptor results in an absence of trunk melanocytes
and agangliosis due to loss of enteric nervous system
progenitor cells in regions of the developing gut (Baynash et
al., 1994; Hosoda et al., 1994; Shin et al., 1999).
Here we provide evidence that ETs influence the devel-
pment of a third neural crest derivative, namely cells of
he Schwann cell lineage. We show that ETs, binding to ETB
receptors, block programmed cell death of Schwann cell
precursors. Intriguingly, ETs also act as a brake on lineage
progression, delaying the generation of Schwann cells from
precursors both in vitro and in developing nerves in vivo.
Copyright © 2000 by Academic Press. All rightMATERIALS AND METHODS
Animals
Sprague–Dawley rats from the breeding colony of University
College London were used for most of this work. Spotting lethal (sl)
rats (from a colony held by D. Cass, Parramatta, Australia), which
lack functional ETB receptors, were used to study the effects of ETB
receptor absence during development. In both cases, females were
time mated and embryos were dated with E0 taken to be the day of
the vaginal plug (Christie, 1965).
Antibodies
Rabbit antiserum to bovine S100 protein (Dako, High Wycombe,
UK) was used at a dilution of 1:10,000. Monoclonal antibody (MAb)
192 IgG, which recognizes the low-affinity p75NGFR, was a gift from
Dr. E. Johnson Jr. (Taniuchi et al., 1986) and was used in the form
of supernatant at a dilution of 1:100. MAb RT97 against neurofila-
ment was a gift from Dr. J. Wood (Anderton et al., 1992) and was
used at a dilution of 1:2000. MAb ASCS4, which in the rat
recognizes the cell adhesion molecule L1 (Sweadner, 1983), was a
gift from Dr. A. Furley; it was used in the form of supernatant at a
dilution of 1:1. MAb against BrdU was a gift from M. Jones and Dr.
D. Mason and was used at a dilution of 1:100. Fluorescein-
conjugated goat anti-rabbit immunoglobulin was from Cappel
Laboratories (ICN, Thame, UK). It was absorbed with mouse
immunoglobulin to remove cross-reacting antibodies and was used
at a dilution of 1:200. Tetramethyl rhodamine-conjugated and
fluorescein-conjugated goat anti-mouse immunoglobulin, from
Cappel Laboratories, were absorbed with rabbit immunoglobulin to
remove cross-reacting antibodies and were used at a dilution of
1:200 and 1:100, respectively. Biotinylated sheep anti-rabbit and
anti-mouse immunoglobulins and streptavidin–fluorescein were
from Amersham International.
Other Materials
Transferrin, selenium, putrescine, triiodothyronine, thyroxine,
dexamethasone, insulin, bovine serum albumin (BSA), hyaluroni-
dase, soya bean trypsin inhibitor, donor calf serum, laminin, and
poly-L-lysine (molecular weight 300,000) were obtained from Sigma
(Poole, UK). Tissue culture petri dishes were from Falcon (Becton–
Dickinson, Cowley, UK) and 24-well plates were from Corning
Costar (High Wycombe, UK). Dulbecco’s modified Eagle’s medium
(DMEM), minimum essential medium (MEM), and Ham’s F12
medium were from Life Technologies (Paisley, UK). Collagenase
was obtained from Worthington (Lorne Laboratories, Reading, UK).
BrdU was from Boehringer Mannheim (Lewes, UK). Tissue-Tek
OCT compound was from Agar (Stansted, UK) and Citifluor was
from Citifluor Ltd. (London, UK).
IGF-1 and FGF-2 were from Peprotech (London, UK). Both b2 and
b3 isoforms of neuregulin were used for these studies with no
ignificant difference seen in the survival or maturation results;
hey have therefore been referred to as b-neuregulin in the text.
hey were a gift from Dr. B. Ratzkin (Amgen, Thousand Oaks, CA).
ndothelins 1 and 2 were from Cambridge Research Biochemicals
Northwich, UK). Endothelin 3, big endothelin-39 (rat), the ETB
receptor inhibitor BQ788, and the neutral metalloprotease inhibi-
tor phosphoramidon were obtained from Sigma. The ETA receptor
nhibitor BQ123 and the ETB receptor agonist IRL 1620 were fromAlexis Corp. (Nottingham, UK).
s of reproduction in any form reserved.
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547Endothelins and Embryonic Schwann Cell DevelopmentAll RT-PCR reagents and primer pairs were from Life Technolo-
gies. Ultraspec RNA total RNA isolation reagent was from Biotecx
Laboratories (Houston, TX).
Defined Medium
Defined medium used in this study was a modification of the
medium of Bottenstein and Sato (1979). A 1:1 mixture of DMEM
and Ham’s F12 was supplemented with (final concentrations in
parentheses) transferrin (100 mg/ml), progesterone (60 ng/ml), pu-
rescine (16 mg/ml), thyroxine (400 ng/ml), triiodothyronine (10.1
ng/ml), dexamethasone (38 ng/ml), selenium (160 ng/ml), glucose
(5 mg/ml), insulin (5.7 ng/ml, 1029 M), IGF-1 (100 ng/ml, 13 nM),
BSA (0.35 mg/ml), penicillin (100 IU/ml), streptomycin (100 IU/
ml), and glutamine (2 mM).
Cell Culture
Preparation of Schwann cells and precursors, survival and replat-
ing assays, and measurement of DNA synthesis were essentially as
described previously (Jessen et al., 1994; Gavrilovic et al., 1995;
Dong et al., 1995). For culture of sl rat precursors and Schwann
cells, sciatic nerves from single embryos were dissociated and
cultured individually (Dong et al., 1999).
Preparation of Tissue for Sections
For unfixed tissue, embryonic hindlimbs were embedded di-
rectly in Tissue-Tek OCT compound and frozen in isopentane over
liquid nitrogen. For S100 staining, the tissue was fixed for 6 h in 4%
paraformaldehyde at 4°C and then in methanol at 220°C over-
night. The tissue was then incubated in 0.3% sucrose in PBS for 1–3
days before being embedded in OCT as above. Ten-micrometer
sections were cut on a Leica 1800 cryostat and mounted on
Superfrost slides before staining.
Immunohistochemistry
For L1 immunolabeling, cells were prefixed in 2% paraformal-
dehyde for 5 min and then incubated with ASCS4 diluted 1:1 with
10% donor calf serum in MEM buffered with 15 mM Hepes for 1 h
at room temperature. Labeling was detected with anti-mouse
biotin followed by streptavidin–fluorescein.
To examine S100 expression on cultured cells, double labeling
was performed using the 192 IgG antibody against the low-affinity
p75NGFR as the first label, since the detection of S100 required the
ame biotin–streptavidin method as L1. We have previously shown
hat this antibody picks up a very small percentage of cells that are
1 negative (Dong et al., 1995). This is likely to bias the S100
xpression toward a lower figure than if L1/S100 double labeling
as performed.
Cells were prefixed in 2% paraformaldehyde for 5 min before
eing incubated with 192 IgG for 30 min at room temperature. This
rst antibody was detected using anti-mouse rhodamine. The cells
ere then fixed in 4% paraformaldehyde for 20 min, permeabilized
ith methanol at 220°C for 10 min, and then blocked for nonspe-
ific binding using a solution containing 10% donor calf serum and
.1 M lysine in PBS (antibody diluting solution) for 30 min. The
ells were then incubated with anti-S100 diluted in the same
olution overnight at room temperature. This was then visualized
sing anti-rabbit biotin and streptavidin–fluorescein.
Copyright © 2000 by Academic Press. All rightDetection of S100 expression in cryosections of hindlimb was
ombined with labeling with an antibody to the phosphorylated
pitope of neurofilament, RT97. Sections were postfixed with 4%
araformaldehyde for 20 min followed by methanol at 220°C for 10
in. The sections were then blocked with antibody diluting
olution for 30 min and incubated with anti-S100 and anti-RT97 in
he same solution overnight at room temperature. The labeling was
etected using anti-rabbit biotin with streptavidin–fluorescein for
100 and anti-mouse rhodamine for RT-97, both for 30 min at room
emperature.
Detection of BrdU incorporation used anti-p75NGFR as the first
abel with anti-mouse fluorescein to detect antibody binding. The
ells were then fixed in methanol at 220°C for 10 min, incubated
ith 2 M HCl for 20 min at room temperature, and washed
horoughly in PBS before being neutralized in 0.1 M sodium borate
olution for 10 min at room temperature. Anti-BrdU was then
pplied in PBS containing 0.1% Triton for 1 h followed by anti-
ouse rhodamine for 30 min at room temperature.
All staining was followed by mounting in Citifluor mounting
edium.
Analysis of double-label immunofluorescence in wild-type and
utant embryonic nerve sections was performed with a Leica TCS
P confocal microscope. The sections were scanned under identical
onditions and the resulting images were processed identically
sing Adobe PhotoShop.
Semiquantitative RT-PCR
Total RNA was made from various tissues of E14 embryos,
whole embryo, spinal cord, dorsal root ganglia (DRG), and sciatic
nerve pooled with brachial plexus, using Ultraspec RNA isolation
reagent according to the manufacturer’s instructions (Biotecx).
Similarly, total RNA was prepared from sciatic nerves and brachial
plexus of postnatal day 0, 3, and 21 rats. RNA (1.5 mg) was reverse
transcribed into cDNA in a 50-ml reaction using random hexamers
s primer and Superscript II reverse transcriptase as described
reviously (Zoidl et al., 1997). The relative amounts of cDNA
ynthesized from each sample were determined by PCR amplifica-
ion using specific primers for 18S rRNA (Owens and Boyd, 1991).
rimer pairs for prepro-ET-1, prepro-ET-3, ETA receptor, ETB recep-
tor, and ECE-1 were as described in Wang et al. (1995).
One microliter of cDNA (equivalent to 100 ng total RNA) was
amplified in a reaction volume of 50 ml containing 13 reaction
uffer; 1.5–2.5 mM MgCl2 (as stated below); 0.2 mM dATP, dGTP,
TTP, and dCTP; 15 pmol each of forward and reverse primers; and
.25 U Taq DNA polymerase. MgCl2, annealing temperature, and
cycle number were optimized for each primer pair and are as
follows: ET-1—1.5 mM MgCl2, 54°C, 32 cycles; ET-3—1.5 mM
MgCl2, 56°C, 32 cycles; ETA receptor—1.5 mM MgCl2, 55°C, 28
cycles; ETB receptor—1.5 mM MgCl2, 56°C, 22 cycles; ECE-1—2.5
M MgCl2, 54°C, 40 cycles.
Except for RT-PCR using 18S primers, the reaction protocol
involved an initial step at 94°C for 3 min, followed by annealing for
1 min and an extension period at 72°C for 3 min. Cycling condi-
tions were 94°C for 15 s, annealing temperature (see above) for 20 s,
and 72°C for 1 min, before a final extension period of 7 min at 72°C.
For 18S PCR, an initial step at 94°C for 3 min was followed by13
cycles of 94°C for 30 s, 50°C for 1 min, and 72°C for 1 min, with a
final extension period of 7 min at 72°C. To check that the product
was accumulating in a linear manner, 1/10 of each reaction was
s of reproduction in any form reserved.
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548 Brennan et al.electrophoresed at 3-cycle intervals (at a stage at which product
accumulation could be visualized) on a 2% agarose gel stained with
ethidium bromide. The number of cycles used in the RT-PCR was
within the linear part of the amplification profile.
Genotyping of sl Rat Embryos
DNA was extracted from small amounts of embryonic brain
tissue by homogenizing in 300 ml 50 mM Tris–HCl (pH 7.5), 20 mM
DTA followed by lysis with 0.2% SDS. The samples were digested
ith 30 mg proteinase K at 55°C for 60 min. Following phenol–
hloroform extraction, DNA was precipitated with sodium acetate
n ice-cold ethanol. After being washed in 70% ethanol, the DNA
as dissolved in TE buffer.
Detection of the mutation in the ETB receptor gene involved PCR
mplification as described in Ceccherini et al. (1995). The primers
sed were PS7 (sense, 59-CCACTAAGACCTCCTGGACT-39) in
exon 2 (147–166 bp) and PS15 (antisense, 59-AGTGTAGCT-
TTCTAAGTCGTGA-39) 172 bp from the 59 end of intron 2. The
expected PCR product from wild type was 527 bp, while the mutant
product was 206 bp, due to a 301-bp deletion in the ETB receptor gene.
ne hundred nanograms of DNA was used in a 25-ml reaction volume
ith 13 reaction buffer, 1.5 mM MgCl2, 20 pmol of each primer, and
.25 U Taq DNA polymerase. Amplification involved an initial step
at 94°C for 3 min, then 35 cycles of 94°C for 30 s, 53°C for 1 min, and
72°C for 2 min followed by a final extension period of 7 min at 72°C.
Ten microliters of reaction product was electrophoresed on a 2%
agarose gel stained with ethidium bromide. PCR of wild-type and 1/sl
embryos gave a DNA product of 527 bp while this was absent in
samples from sl/sl embryos.
RESULTS
ET Receptor mRNAs and Prepro-ET mRNAs Are
Expressed in the Developing Peripheral Nervous
System
Using primers described previously for the rat ETA and
TB receptors (Wang et al., 1995) and semiquantitative
RT-PCR, we looked for ET receptor mRNA in E14 nerve,
DRG, spinal cord, and newborn nerve. All of these tissues
contained mRNA for both ETA and ETB receptors (Fig. 1).
n E14 and newborn nerve, the PCR signals for ETA and
ETB receptors were of similar strength, although E14
DRG and spinal cord both expressed higher levels of ETB
mRNA with spinal cord having very low levels of ETA
mRNA. By comparison, the level of ETB receptor mRNA
n whole E14 embryo was extremely low compared to the
evel of ETA receptor. This indicates that the nervous
ystem, and in particular tissue containing nerve cell
odies, is enriched in ETB receptors, while Schwann cells
and their precursors express comparable levels of both
receptor types.
Examining the expression of prepro-ET mRNA, we
found that both prepro-ET-1 and prepro-ET-3 mRNAs are
present in E14 nerve, DRG, and spinal cord. By birth, the
relative levels of prepro-ET-3 have dropped in the sciatic
nerve so that prepro-ET-1 is the predominant endothelin
mRNA present (Fig. 1). RT-PCR was also used to show
Copyright © 2000 by Academic Press. All righthat the mRNA for ECE-1 was expressed in the develop-
ng nerve, DRG, and spinal cord; see also below and Fig.
.
Endothelins Are Survival Factors for Schwann Cell
Precursors in Vitro
ET-1, -2, or -3 in the presence of 100 ng/ml IGF-1
promoted the survival of Schwann cell precursors obtained
from limb nerves of E14 rat embryos in a standard 20-h
assay described previously (Jessen et al., 1994; Dong et al.,
1995; Gavrilovic et al., 1995). All three ETs promoted
urvival with similar survival maxima at similar concen-
rations (Fig. 2A). Maximal survival of around 80% was
een with concentrations of ETs above 0.3 nM. To test
hether the survival-promoting effect of ETs depended on
he presence of IGFs, we compared the effects of a supra-
aximal dose of ET-1 (5 nM) in the presence or absence of
GF-1. Although the absence of IGF-1 reduced considerably
he number of surviving cells, about 40% survival was
bserved in the presence of ET-1 alone (Fig. 2B). This
ontrasts with the survival-promoting effect of FGFs, which
re entirely dependent on the presence of IGFs (Gavrilovic
t al., 1995).
Antagonists of the Receptors Can Block ET
Function
The dose–response curves for precursor survival in the
presence of ETs were very similar (Fig. 2A). This suggested
FIG. 1. mRNAs for ETA and ETB receptors and for ET-1, ET-3, and
ECE-1 in the developing nervous system. Semiquantitative RT-
PCR was performed on samples from E14 spinal cord, DRG, nerve,
and whole embryo and sciatic nerve from newborn (P0), postnatal
day (P) 3, and P21 rats. The synthesis of equal amounts of cDNA
from total RNA was verified by RT-PCR with 18S rRNA primers.that the survival effects were mediated via the ETB receptor
s of reproduction in any form reserved.
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549Endothelins and Embryonic Schwann Cell Developmentsince the ETA receptor has much higher affinity for ET-1
than for ET-3, while the ETB receptor shows similar affinity
for all three ETs. To investigate this further, increasing
doses of ETA and ETB antagonists were used in assays with
onstant concentrations of either ET-1 or ET-3. The ETA
FIG. 2. (A) ET-1, -2, and -3 support the survival of Schwann cell
precursors in vitro. Precursors were cultured in defined medium
containing 100 ng/ml IGF-1 and increasing concentrations of ET-1,
ET-2, or ET-3. Survival was calculated as the percentage of L11
precursors surviving at 20 h after plating compared to the number
of cells that had attached and flattened 3 h after plating as described
elsewhere (Dong et al., 1995). (B) ET-1 requires the presence of
IGF-1 for maximal survival effect. Precursors were plated in defined
medium without IGF-1 for 3 h. They were then topped up with
medium containing one of the following: IGF-1 (100 ng/ml), ET-1 (5
nM), IGF-1 (100 ng/ml) 1 ET-1 (5 nM), or b-neuregulin (NRG; 10
ng/ml) 1 IGF-1 (100 ng/ml). Survival was calculated at 20 h as
mentioned above. The number of cells at 20 h in the presence of
b-neuregulin is above 100% due to cell proliferation induced by the
high concentration of b-neuregulin used in this experiment (see
lso Fig. 4).receptor antagonist BQ123 (Ihara et al., 1992) used in a m
Copyright © 2000 by Academic Press. All rightoncentration range of 1 nM–10 mM did not affect the
survival-promoting effects of either ET-1 or ET-3 used at 5
nM (Fig. 3A). In contrast to this, the ETB receptor-specific
FIG. 3. ETs promote precursor survival via the ETB receptor. (A)
The ETA receptor antagonist, BQ123, was used at increasing
concentrations in defined medium containing 100 ng/ml IGF-1 and
either 5 nM ET-1 or 5 nM ET-3. (B) The ETB receptor antagonist,
Q788, was used at increasing concentrations in the presence of
ither 5 nM ET-1 or 5 nM ET-3 in defined medium containing 100
g/ml IGF-1. Survival in A and B was calculated as described
reviously. (C) Increasing concentrations of IRL 1620 were added in
efined medium containing 100 ng/ml IGF-1. The graph also shows
he survival produced by 5 nM ET-1 in the same series of experi-
ents. Survival after 20 h was calculated as described previously.
s of reproduction in any form reserved.
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550 Brennan et al.antagonist BQ788 (Ishikawa et al., 1994) caused a strong
decline in precursor survival when used at concentrations
above 10 nM in the presence of either ET-1 or ET-3 at 5 nM
(Fig. 3B).
Agonists of ETB Block Precursor Death
To confirm that precursor survival required activation of
the ETB receptor, we tested whether the ETB receptor
agonist, IRL 1620, could be used to support precursor
survival. A substantial number of cells survived in the
presence of this compound. The maximum response, seen
at 5 mM IRL 1620, was about 60% of that obtained with
ET-1 in parallel experiments (Fig. 3C).
This observation, together with the equipotency of all
three ETs and the reduction in survival in the presence of
the ETB receptor antagonist but not the ETA receptor
ntagonist, suggests that ETs are acting via the ETB receptor
to promote precursor survival.
ETs Are Not Mitogens for Precursors under the
Conditions Used in the Survival Assays
To determine whether ETs acted as precursor mitogens,
we used a strategy developed previously for detecting mi-
togenic effects of growth factors on precursors (Dong et al.,
1995).
We found that, in the presence of 5 nM ET-1 in defined
medium containing 100 ng/ml IGF-1, only 2 6 0.9% of cells
incorporated BrdU during a 1.5-h pulse at 18.5 h after
FIG. 4. The mitogenic effects of growth factors on precursors.
Precursors were cultured in defined medium containing 100 ng/ml
IGF-1 and one of the following for 20 h: FGF-2 (3 ng/ml), ET-1 (5
nM), b-neuregulin (NRG; 5 ng/ml), FGF-2 (3 ng/ml) 1 ET-1 (5 nM).
After 18.5 h in culture, 20 mM BrdU was added and the cells were
cultured for a further 1.5 h. The cells were stained for L1 expression
and BrdU incorporation and the results are expressed as the
percentage of L1-positive cells that have BrdU-positive nuclei.plating (Fig. 4). We also confirmed that the combination of
Copyright © 2000 by Academic Press. All rightGFs and IGFs, without ETs, is not mitogenic for rat
chwann cell precursors (Gavrilovic et al., 1995). We con-
lude that the combination of ETs and IGF-1 does not
timulate DNA synthesis and that cell division does not
ontribute significantly to the number of precursors surviv-
ng in the experiments described above.
Proliferation of other neural crest derivatives in the
resence of ETs and serum has been described previously
Lahav et al., 1996, 1998; Reid et al., 1996; Stone et al.,
1997). We observed that a combination of ET-1, FGF-2, and
IGF-1 stimulated division of the precursors. When exposed
to these three factors together the percentage of cells
synthesizing DNA increased to 23 6 4.7%, using a 1.5-h
BrdU pulse at 18.5 h, suggesting that ETs require additional
factors for mitogenic activity.
ETs Are Long-Term Survival Factors for Precursors
We have shown elsewhere that b-neuregulins act as
long-term in vitro survival factors for rat Schwann cell
recursors while FGFs support only short-term survival of
hese cells (Dong et al., 1995; Gavrilovic et al., 1995; see,
however, Dong et al., 1999, for mouse cells).
To see whether ETs could promote long-term survival of
precursors from rat nerves, cells from E14 nerves were
exposed to ET-1 for 4 days. The cultures were fed with fresh
medium every day.
When the number of surviving precursors adherent to the
coverslip at the end of the 4-day period was compared to the
number of cells that had attached and flattened after 3 h in
FIG. 5. Longer term exposure of precursors to b-neuregulin or
T-1. Precursors were cultured in defined medium with 100 ng/ml
GF-1 and either 5 ng/ml b-neuregulin (NRG) or 5 nM ET-1. The
cells were fixed and stained for L1 expression after 20, 44, 68, and
92 h. Since many living cells detach from the coverslips in the
presence of ET-1 (see text) the numbers indicated here underesti-
mate the total number of cells that live in the presence of ET-1.
s of reproduction in any form reserved.
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551Endothelins and Embryonic Schwann Cell Developmentculture it amounted to around 40% of the original cell
number (Fig. 5). During the experiment it was observed that
areas of cells aggregated to form small mounds of cells,
perhaps indicating increased cell–cell adhesion. Other cells
retracted their processes from the substrate and in some
areas cells became detached from the coverslips. These
detached cells could be rescued by collecting the medium
and replating the cells on new coverslips in fresh medium,
suggesting that they were not dying but rather that the
cell–substrate adhesion was less than optimal (not shown).
We conclude from this that the 40% survival figure at this
time point represents an underestimate of the number of
precursors that survive in ET due to the detachment of
living cells from the coverslips.
Precursors Need the Mature Form of ETs for
Survival
Generation of active endothelins from the relatively
inactive precursor molecules, known as big endothelins,
requires the action of specific ECEs. RT-PCR using primers
to ECE-1 (Wang et al., 1995) revealed that ECE-1 is present
t E14 in nerve, DRG, and spinal cord; in newborn; and in
3 nerve (Fig. 1), suggesting that active ETs can be gener-
ted in areas where they could influence Schwann cell
recursors and Schwann cells.
To determine whether big endothelins could be cleaved
y precursors in culture, a dose–response curve was con-
tructed using big ET-1. Significant survival was seen only
hen concentrations of about 10 nM or higher were used
Fig. 6A). Big ETs acting directly on ET receptors effect
esponses similar to those of ETs at concentrations 2 orders
f magnitude higher than those required for mature endo-
helin (Turner and Murphy, 1995). By comparison with
T-1, the EC50 for precursor survival is shifted to the right
in big ET, a concentration increase of approximately 100—
from 0.02 to 2 nM. These data indicate that precursors in
vitro are not able to cleave the inactive molecule to gener-
ate enough mature ET-1 for cell survival and that the
survival effects seen in big ET are due to direct action of
high concentrations of big ET-1 on ET receptors.
The ECEs are neutral metalloproteases and are sensitive
to the enzyme inhibitor phosphoramidon (Turner and Mur-
phy, 1995). This inhibitor also blocks the activity of the
endopeptidase 24.11 present in Schwann cells (Kioussi et
al., 1995), which, although not an ECE, has been reported to
cleave big ETs (Turner and Murphy, 1995). To examine
further whether precursors can cleave big endothelin, in-
creasing concentrations of phosphoramidon were added in a
20-h survival assay using constant concentrations of either
ET-1 (5 nM) or big ET-1 (5 nM). At concentrations of
phosphoramidon reported to block the activity of ECEs,
namely 10 nM–1 mM (Sokolovsky et al., 1990; Ikegawa et
l., 1991; Takada et al., 1991), no effect was seen on the
esponse of the precursors to big ET-1 (Fig. 6B). However, at
igher concentrations, a decrease in survival was observed
n both ET-1 and big ET-1, suggesting that this was due to t
Copyright © 2000 by Academic Press. All rightoxic effects on the cells. Taken together, these results
ndicate that Schwann cell precursors do not convert big ET
o mature ET in any significant manner in vitro.
ETs Do Not Promote Precursor Maturation in
Vitro
Mutant mice lacking b-neuregulins or their receptors
ave shown that these growth factors are essential regula-
FIG. 6. (A) A comparison of the effects of big ET-1 and ET-1 on
precursor survival. Increasing concentrations of either big ET-1 or
ET-1 were used in defined medium containing 100 ng/ml IGF-1.
Survival was determined at 20 h after plating as described earlier.
(B) The effect of phosphoramidon on precursor survival in ET-1 and
big ET-1. Precursors were cultured in defined medium containing
100 ng/ml IGF-1 and either ET-1 (5 nM) or big ET-1 (5 nM) in the
presence of increasing concentrations of phosphoramidon. Survival
was measured at 20 h as described previously.ors of Schwann cell development in vivo (Meyer and
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552 Brennan et al.Birchmeier, 1995; Riethmacher et al., 1997; Wolpowitz et
l., 2000). Culture of Schwann cell precursors in the pres-
nce of b-neuregulins promotes not only long-term survival
of these cells, but also the maturation of precursors to
Schwann cells with a time course that is similar to that
seen in vivo (Dong et al., 1995).
We examined, therefore, the effect of ETs on Schwann
cell precursor maturation in vitro using an assay system
described previously (Dong et al., 1995). Briefly, precursors
were cultured for 4 days in defined medium containing
ET-1 or b-neuregulin, then enzymatically removed from the
substrate, spun down, and replated in defined medium
alone (containing IGF-1) without ET-1 and b-neuregulin.
The appearance of Schwann cells from precursors can be
assessed by monitoring a number of phenotypic changes
(Jessen and Mirsky, 1999). The two criteria used here were
(a) expression of cytoplasmic S100 protein 3 h after replat-
ing and (b) survival of the replated cells for 20 h in defined
medium. After 4 days in vitro in b-neuregulin, 87 6 1%
(n 5 3) of cells expressed S100 protein and 92 6 6% (n 5 3)
of cells survived for 20 h in defined medium, indicating that
about 90% of the cells have matured to Schwann cells (Fig.
7). These figures are in agreement with previous work and
FIG. 7. The effects of b-neuregulin and ET-1 on Schwann cell
precursor maturation in vitro. Precursors were cultured in defined
medium containing 100 ng/ml IGF-1 with either 5 ng/ml
b-neuregulin (NRG) or 5 nM ET-1 or both together for 4 days, with
cultures being fed daily. The cells were then washed, enzymatically
removed from the substrate, and replated on coverslips in defined
medium containing 100 ng/ml IGF-1 only. Three hours after
plating some coverslips were fixed and stained for p75NGFR and
S100. The number of cells expressing S100 is expressed as a
percentage of cells that also express p75NGFR. The remaining cover-
lips were either stained for L1 after 3 h or cultured for a further
7 h (20 h after plating) before staining for L1. The percentage
urvival was calculated as the number of cells surviving and
xpressing L1 at 20 h after plating compared to the number of L1 1
ells 3 h after plating.very similar to those obtained with cells dissociated di- m
Copyright © 2000 by Academic Press. All rightrectly from E18 nerves (equivalent to E14 1 4 days) plated
in defined medium (96% express S100 protein and 98%
survive to 20 h; Dong et al., 1995). However, in the presence
of either ET-1 (Fig. 7) or ET-3 (data not shown) the majority
of surviving precursors fail to mature into Schwann cells.
Only 16 6 2% (n 5 3) of the replated cells expressed S100
protein and 17 6 1% (n 5 3) of replated cells survived for
0 h following replating. Thus most of the cells that
urvived for 4 days in ETs remain at the precursor stage,
ather than progressing to form Schwann cells.
ETs Block Precursor Maturation Effects of b-
euregulins
Next we examined whether ETs could interfere with the
Schwann cell generation from precursors that normally
takes place in b-neuregulin. ET-1 at 5 nM was added to
cultures containing 5 ng/ml (200 pM) b-neuregulin and the
edium changed every day for 4 days. The cells were then
eplated as described previously. Under these conditions,
nly 38 6 10% of cells expressed S100 protein and 50 6 8%
urvived to 20 h in defined medium (Fig. 7). Thus ETs
trongly retard the maturation of Schwann cell precursors
nd delay the appearance of cells with the Schwann cell
henotype even in the presence of a promoter of precursor
aturation.
ET Removal Restores the Maturation-Promoting
Activity of b-Neuregulin
It was possible that endothelin was affecting the fate of
the Schwann cell precursors, not only delaying their matu-
ration to Schwann cells but also directing them toward
alternative neural crest-derived lineages. To study this
precursors were cultured for 4 days in 5 nM ET-1 alone and
then replated and cultured for a further 3 days with either
ET-1 or 5 ng/ml b-neuregulin. For comparison some cells
ere cultured in b-neuregulin for 4 days before replating
and culturing for a further 3 days in 5 ng/ml b-neuregulin.
The cells that were cultured in ET-1 for 4 1 3 days showed
n increase in the percentage of cells expressing S100, from
7% after 4 days to 58% after 4 1 3 days (Fig. 8). However,
ells that were removed from ET and replated in
b-neuregulin showed a greater increase with 83% of cells
expressing S100. This figure was comparable to S100 ex-
pression seen in cells that were exposed to neuregulin for
the whole experiment, of which 86% were S100 positive in
this series of experiments (Fig. 8). These data suggest that
ETs delay rather than block the progression of the precur-
sors to the Schwann cell phenotype. They also indicate that
the lack of Schwann cells in precursor cultures exposed to
ET for 4 days is not due to diversion of the cells into other
lineages. Importantly, these results indicate that, at least in
itro, b-neuregulins are not essential for the generation of
chwann cells from their precursors and suggest the exis-
ence of an intrinsic mechanism that promotes precursor
aturation.
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553Endothelins and Embryonic Schwann Cell DevelopmentRats Lacking a Functional ETB Receptor Show
Early Expression of a Schwann Cell Marker
Since ETs regulated the rate of precursor development in
vitro we examined whether they also controlled the timing
of Schwann cell development in vivo. To investigate this,
we studied Schwann cell development in sciatic nerve of
the sl rat, which lacks functional ETB receptors as a result of
small deletion in the ETB receptor gene (Cecchini et al.,
995; Gariepy et al., 1996).
Heterozygote (1/sl) rats were time mated and litters were
enotyped at E15 and E16. Embryos were fixed before
indlimbs were removed for cryosectioning and staining for
100 to monitor the appearance of Schwann cells and RT97
o detect areas of nerve tissue. At E15, nerves from wild-
ype embryos were essentially negative for S100 protein as
xpected (Fig. 9A) (Jessen et al., 1994). In contrast, similar
erves from sl/sl embryos contained S1001 cells (Fig. 9B).
y E16, many cells within developing nerves of sl/sl em-
ryos strongly expressed S100 protein (Figs. 9D and 9F).
owever, in comparable nerves from 1/1 animals far fewer
ells expressed S100 and the levels of expression were much
ower (Figs. 9Cand 9E). The strong expression of S100
ithin developing chondrocytes (Figs. 9C and 9D) has been
eported previously (Landry et al., 1990).
FIG. 8. The effects of longer term culture with either ET-1 or
b-neuregulin on S100 expression. Precursors were cultured in
defined medium containing 100 ng/ml IGF-1 and either ET-1 (5
nM) or b-neuregulin (NRG; 10 ng/ml) for 4 days before replating
and culturing for a further 3 days. Cells previously cultured in ET-1
were exposed to either ET-1 (5 nM) or b-neuregulin (10 ng/ml) for
the last 3 days, while cells cultured previously in b-neuregulin
ere exposed only to further b-neuregulin. Cells were stained for
75NGFR and S100 expression at 3 h after replating on day 4 and at
the end of the 7 days in culture. S100 expression is given as the
percentage of p75NGFR-positive cells that also express S100.Examining this further, nerves from individual embryos n
Copyright © 2000 by Academic Press. All rightere dissociated and cultured as described previously. In
reparations from wild-type E16 rats, 47 6 3% (n 5 8) of
he cells expressed S100 protein and 7 6 2% survived for
0 h in defined medium with IGF-1 (100 ng/ml), while in
reparations from heterozygous rats 47 6 2% (n 5 25) of
he cells expressed S100 and survival was 6 6 1%. These
alues are in agreement with previous work on normal rats.
y comparison, in homozygous mutant rats the number of
ells expressing S100 protein was increased by nearly 50%
o 67 6 2% (n 5 14), in line with the observations in vivo.
his increase in the number of cells expressing a marker for
chwann cells was not reflected in an increase in survival,
hich remained low at 9 6 1%.
We conclude, first, that the loss of ET signaling in vivo
eads to an earlier expression of a marker for transition to a
chwann cell phenotype, namely the expression of S100
rotein and, second, that these “premature Schwann cells”
ave not yet acquired another characteristic of the Schwann
ell phenotype, namely autocrine survival support. A dis-
repancy in this direction might be expected, since the
urvival rate of the population lags behind the number of
100-positive cells at this period (E16) of nerve develop-
ent (Jessen et al., 1994, and data above).
DISCUSSION
We have shown that ETs can promote long-term survival
of Schwann cell precursors in the absence of proliferation
while RT-PCR data show that these cells have mRNA for
both ETA and ETB receptors. Isoform survival data together
ith receptor agonist and antagonist studies indicate that
Ts act through the ETB receptor. Although ETs are not
itogens for precursors RT-PCR data show that ET-1 and
T-3 mRNAs are present in the developing PNS and thus
ould influence Schwann cell development. Perhaps the
ost significant finding in the present work is the observa-
ion that ETs delay Schwann cell maturation in vitro and in
ivo. We have previously shown that in the presence of
b-neuregulin, E14 precursors mature to Schwann cells in
vitro approximately on schedule, i.e., during a period of 4
days (Dong et al., 1995). We find that ETs inhibit Schwann
cell generation in this system and that if precursors are
maintained for 4 days in ET, rather than b-neuregulin, most
of the cells remain as precursors rather than progress to
form Schwann cells. Furthermore, Schwann cell develop-
ment is accelerated in the absence of ET signaling, as
evidenced by an increase in the number of S100-positive
cells in embryonic nerves of ETB receptor-deficient rats at
15 and E16, the time of precursor/Schwann cell conver-
ion. This is the expected result if ETs function in vivo, as
n vitro, as negative regulators of Schwann cell develop-
ent. Together these observations suggest that ET signal-
ng plays a part in the timing mechanism that controls
chwann cell generation in vivo.
The present experiments also address the importance ofeuregulins for lineage progression in this system. Numer-
s of reproduction in any form reserved.
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555Endothelins and Embryonic Schwann Cell Developmentous in vivo and in vitro studies show that neuregulins affect
urvival, proliferation, migration, and differentiation of
chwann cells and their precursors, indicating that neu-
egulins are key regulators of early Schwann cell develop-
ent. However, we find that most Schwann cell precursors
onvert to Schwann cells after prolonged (7 day) exposure to
T in the absence of neuregulins. The action of ETs is,
herefore, to delay, but not block, Schwann cell generation.
his means that the generation of Schwann cells from
recursors does not require neuregulins. Nevertheless, neu-
egulins seem to actively promote precursor maturation
ince addition of b-neuregulin to precursors in endothelin
ccelerates the generation of Schwann cells from precur-
ors.
ET Receptors
Several observations indicate that Schwann cell precursor
survival by ETs is mediated by the ETB receptor: (i) all three
ET isoforms promote precursor survival with similar dose–
response curves and maxima; (ii) the ETA receptor antago-
nist BQ123 does not affect the survival response of precur-
sors to ETs, while addition of the ETB receptor antagonist
brogates the response; and (iii) the ETB receptor agonist can
romote precursor survival. Furthermore, RT-PCR revealed
hat Schwann cell precursors and Schwann cells express
RNA for both ETA and ETB receptors. However, the above
vidence would suggest that ETA receptors are not actively
involved in precursor survival.
These results are consistent with observations in the
quail embryo, in which in situ hybridization revealed
expression of ETB receptor transcripts in peripheral nerves
Nataf et al., 1996). Immortalized Schwann cells have also
been reported to express functional ETB receptors (Wilkins
et al., 1997). The expression of this receptor by Schwann
cell precursors is not unexpected since trunk neural crest
cells, from which they are derived, express ETB receptors
(Nataf et al., 1998). Two other neural-crest-derived lineages,
melanocytes and enteric neurons, not only express ETB
receptors but also display an absolute requirement for the
action of ET during their development. Loss of functional
ETB receptors, resulting from a mutation in the receptor
ene, gives rise to animals with coat color spotting due to a
oss of melanocytes and agangliosis of the hindgut due to a
ack of enteric neurons (Baynash et al., 1994; Hosoda et al.,
994; Puffenberger et al., 1994; Ceccherini et al., 1995;
ariepy et al., 1996).
We have previously tested many growth factors for
FIG. 9. Schwann cells develop ahead of schedule in embryonic ner
ith antibodies against neurofilament (red) and S100 (green). The
mbryos and treated identically. (B) Section of E15 sl/sl nerve in wh
his expression is absent from 1/1 nerves (A), in which similar reg
mbryos revealed an even more striking difference: a few S1001 cstrong S100 expression is found in many cells of sl/sl nerves (D, F, arro
Copyright © 2000 by Academic Press. All righturvival-promoting effects on precursors with only the b
isoforms of neuregulin and the combination of FGFs and
IGFs showing significant survival activity (Jessen et al.,
994; Gavrilovic et al., 1995; Dong et al., 1995). Thus ETs
re only the fourth family of growth factors shown to be
ble to promote precursor survival. While IGFs are essential
or the survival-promoting effects of FGFs 1, 2, and 4
Gavrilovic et al., 1995), ET alone promotes approximately
0% of the survival observed when IGF-1 is also present;
GF-1 alone has negligible survival activity.
ETs Delay Progression along Crest-Derived
Lineages
The delay in differentiation of Schwann cells observed in
these studies is in agreement with recent in vitro investi-
gations on both cultured trunk neural crest cells and
enteric-derived neural crest cells (Lahav et al., 1996; Stone
et al., 1997; Hearn et al., 1998; Wu et al., 1999). Using
cultured quail neural crest cells, Lahav et al. (1996) showed
that addition of ET-3 to the cultures delayed both melano-
cyte and glial differentiation. Stone et al. (1997), using
colony and clonal analysis of quail neural crest cultures,
observed that addition of ET-3 maintained multipotential
cells and delayed terminal differentiation for longer than
was observed in the absence of ET-3. Similarly, Hearn et al.
(1998) and Wu et al. (1999) both described how addition of
ET to cultures of enteric-derived neural crest cells delayed
the differentiation of these cells into enteric neurons. In
vivo studies on temporal requirements for ETB receptor
ignaling during neural crest development (Shin et al., 1999)
ave indicated that for normal development of both mela-
ocytes and enteric neurons there exists a window of
equirement for ET signaling via the ETB receptor. In both
hese cases, ET is required to maintain the precursor cells in
n undifferentiated state that permits migration, ensuring
orrect distribution of these cells before the final stage of
ifferentiation.
It has been observed that, in the Schwann cell lineage,
chwann cell precursors are highly motile cells while
chwann cells from the normal nerve are less motile (Jessen
t al., 1994). Preventing premature differentiation would
herefore aid distribution of precursors along the full-length
f the nerve prior to the phase of Schwann cell differentia-
ion and proliferation observed just before birth.
While the effect of ETs in delaying the differentiation of
eural crest derivatives appears to be similar for the three
ystems mentioned, it is interesting to note that the growth
f sl/sl rats. Cryostat sections of E15 and E16 hindlimb were stained
ions were taken from the same axial level in both 1/1 and sl/sl
100 expression can be clearly seen in precursors (arrows). However,
within the nerve appear negative (arrowheads). Sections from E16
an be seen in sections from 1/1 nerves (C, E, arrowheads) whileves o
sect
ich S
ions
ells c
ws).
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556 Brennan et al.factors controlling maturation in each of the systems are
different. For example, Schwann cell maturation appears to
be driven by b-neuregulins but enteric nervous system
differentiation is driven by glial-derived neurotropic factor
(Hearn et al., 1998). This implies that ETs are not interfer-
ng with a specific growth factor signaling pathway, but
hat they act to modulate a generic neural crest differentia-
ion pathway.
The finding that Schwann cell maturation is accelerated
n vivo in the absence of ET signaling identifies ET as the
rst factor known to regulate the timing of Schwann cell
evelopment in vivo. Previously, another factor present in
developing nerves, FGF-2, was shown to accelerate
Schwann cell maturation from mouse Schwann cell precur-
sors in vitro (Dong et al., 1999). Taken together, this
observation and the results presented here suggest that the
role of ETs in delaying Schwann cell precursor differentia-
tion may be part of a complex system of growth factor
control regulating the timing of glial development in pe-
ripheral nerves.
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